SCIPIO brings new momentum to cardiac cell therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.Circulation · 2012
   Trial
2. Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells.Oncotarget · 2017
   Article
3. Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells.Basic research in cardiology · 2015
   Article
4. Regenerative principles enrich cardiac rehabilitation practice.American journal of physical medicine & rehabilitation · 2014
   Review
5. Cell therapy for cardiac repair--lessons from clinical trials.Nature reviews. Cardiology · 2014
   Review
6. How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Basic research in cardiology · 2013
   Review
7. CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving.Global cardiology science & practice · 2013
   Article
8. Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.Basic research in cardiology · 2012
   Article
9. Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.Basic research in cardiology · 2012
   Article
10. Coronary collateral growth--back to the future.Journal of molecular and cellular cardiology · 2012
    Review

Corrections and comments

• Comment on
  Retracted: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as